Key Metrics
CiteScore 

1.3
Eigenfactor 

0.001 - 0.005
Impact Factor 

10 - 15
Scite Index 

0.92 5-Year SI

Recommended pre-submission checks
Powered by 

Topics Covered on Clinical and Translational Medicine
Clinical and Translational Medicine Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | JOHN WILEY & SONS LTD |
| Language | English |
| Frequency | Article-by-article |
| Article Processing Charges | USD 3000 |
| Publication Time | 4 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Shanghai Institute of Clinical Bioinformatics |
| Frequency | Article-by-article |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Clinical and Translational Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical and Translational Medicine
Unlocking beta cell health: The clinical potential of extracellular vesicles in type 1 diabetes
- 18 May 2026
- Clinical and Translational Medicine
Tumour\u2010derived SAA1 reprogrammes macrophages to promote CXCL1\u2010mediated metastasis in Ovarian Cancer
- 18 May 2026
- Clinical and Translational Medicine
A multi\u2010centre, prospective trial of a methylation\u2010based liquid biopsy for early detection of liver cancer in high\u2010risk populations
- 18 May 2026
- Clinical and Translational Medicine
Improving detection of colorectal cancer: A Bayesian approach to serial circulating tumour DNA testing following curative\u2010intent treatment.
- 18 May 2026
- Clinical and Translational Medicine
TMEM92 shields DDX3X from TTC3\u2010mediated degradation to confer chemoresistance in triple\u2010negative breast cancer
- 15 May 2026
- Clinical and Translational Medicine
Tissue\u2010specific targeting of the ARF6 signalling axis for type 2 diabetes and obesity: From mechanism to nanodelivery
- 14 May 2026
- Clinical and Translational Medicine
Unlocking beta cell health: The clinical potential of extracellular vesicles in type 1 diabetes
- 18 May 2026
- Clinical and Translational Medicine
Tumour\u2010derived SAA1 reprogrammes macrophages to promote CXCL1\u2010mediated metastasis in Ovarian Cancer
- 18 May 2026
- Clinical and Translational Medicine
A multi\u2010centre, prospective trial of a methylation\u2010based liquid biopsy for early detection of liver cancer in high\u2010risk populations
- 18 May 2026
- Clinical and Translational Medicine
Improving detection of colorectal cancer: A Bayesian approach to serial circulating tumour DNA testing following curative\u2010intent treatment.
- 18 May 2026
- Clinical and Translational Medicine
TMEM92 shields DDX3X from TTC3\u2010mediated degradation to confer chemoresistance in triple\u2010negative breast cancer
- 15 May 2026
- Clinical and Translational Medicine
Tissue\u2010specific targeting of the ARF6 signalling axis for type 2 diabetes and obesity: From mechanism to nanodelivery
- 14 May 2026
- Clinical and Translational Medicine